Nanophthalmic eyes (N = 32) | Normal eyes (N = 35) | P value | |
---|---|---|---|
Age (years) | 52.83 ± 20.29 | 57.91 ± 12.79 | 0.320 |
Sex (male/female) | 6/12 | 12/23 | 1.000 |
Eye (OD/OS) | 15/17 | 17/18 | 0.890 |
CCT (μm) | 550.16 ± 48.85 (478.00–664.00) | 542.51 ± 26.92 (504.00–602.00) | 0.642 |
AL (mm) | 16.87 ± 1.02 (15.32–18.49) | 23.09 ± 0.88 (21.67–24.50) | < 0.001b |
ACD (mm) | 1.75 ± 0.50 (0.97–3.10) | 2.88 ± 0.51 (2.12–3.96) | < 0.001b |
LT (mm) | 4.70 ± 0.37 (3.98–5.63) | 4.64 ± 0.40 (4.00–5.53) | 0.574 |
Preoperative BCVA (logMAR) | 1.21 ± 0.77, 1 light perception | 0.52 ± 0.16 | < 0.001b |
Follow-up BCVA (logMAR) | 1.03 ± 0.74, 1 light perception | 0.13 ± 0.60 | < 0.001b |
Preoperative IOP (mmHg) | 16.13 ± 3.72 (11.0–24.0) | 15.62 ± 2.59 (8.9–19.6) | 0.612 |
Follow-up period (month) | 13.4 ± 3.3 | 12.2 ± 3.8 | 0.133 |